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INTRODUCTION
S. marcescens, a ubiquitous environmental gram-
negative organism, is a recognized cause of out-
breaks in NICUs (Hejazi et al., 1997). It is an im-
portant opportunistic pathogen and it may cause
serious infections in newborns including sepsis,
pneumonia, brain abscess and meningitis (Polilli
et al., 2011). Reports of S. marcescens outbreaks
in NICUs have increased in the last decade
(Miranda-Novales et al., 2003; Giles et al., 2006)
identifying low birth weight and prematurity as
major risk factors for invasive infections with a
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significant impact on both infant morbidity and
mortality (Arslan et al., 2010).
Several possible environmental sources of S.
marcescens in hospitals have been implicated
(Madani et al., 2011; Cullen et al., 2005; Civen et
al., 2006; Sartor et al., 2000), but no point of
source has been identified (Prasad et al., 2001;
Maragakis et al., 2008). Colonized symptom-free
patients have been recorded as the most impor-
tant reservoir of the bacterium (Fleisch et al.,
2002; Miranda et al., 1996; Voelz et al., 2010).
High patient density and low nurse-to-patient ra-
tio have also been reported as potential sources
for the spread of the pathogen via contaminated
hands of healthcare workers (Milisavljevic et al.,
2004; Gillespie et al., 2007). Typically the man-
agement of such outbreaks includes patient iso-
lation, cohort nursing of the infected and colo-
nized infants, strict hygienic measures, and ward
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closure (Assadian et al., 2002; Buffet-Bataillon et
al., 2009; Perotti et al., 2007).
Once entrenched in an NICU, S. marcescens is
difficult to eradicate and this condition causes
persistent problems and occasionally recurrent
outbreaks (Bosi et al., 1996; Miranda et al., 1996;
Sarvikivi et al., 2004). Thus, a satisfactory typing
method is important in determining the source
of infection, the dynamics and the evolution of
S. marcescens strains during outbreaks (Hejazi et
al., 1997; Steppberger et al., 2002; David et al.,
2006; Enciso-Moreno et al., 2004; Ligozzi et al.,
2010). In recent times ESBLs have had a large
spread in the hospital environment and outbreaks
in NICU settings due to ESBL-producing S.
marcescens have been reported in Italy (Villari et
al., 2001; Crivaro et al., 2007).
Herein, we detail the investigation of two long-
term multiphase outbreaks, both caused by sev-
eral genetically unrelated S. marcescens strains,
that occurred in a NICU of a tertiary care hospi-
tal in Northern Italy, within a 10-year prospec-
tive observational period from January 2003 to
December 2012.
Aims of the present study were:
1) to analyze the molecular epidemiology of S.
marcescens isolates in outbreaks;
2) to evaluate risk factors for S. marcescens ac-
quisition in NICU patients through a case-con-
trol study;
3) to implement appropriate control measures.
MATERIALS AND METHODS
This study is consistent with the Declaration of
Helsinki and was subject to an assessment of the
local ethics committee.
Setting 
The NICU of Modena University Hospital has
20 beds for the admission of critically ill new-
born infants: 2 isolation rooms, each with a sin-
gle bed, 2 intensive care rooms, each with 3 in-
tensive care beds and 12 intermediate care beds
shared amongst 3 rooms. Nurse-to-patient ratio
ranges from 1:3 to 1:4 for intensive care beds
and 1:6 for intermediate care beds. 
Approximately 400 newborns are admitted to
the NICU annually, born at the same centre or
in provincial hospitals.
S. marcescens had never been isolated in the NICU
before January 2003. From January to March
2003, 2 cases of S. marcescens invasive infection
and 4 cases of colonization marked the onset of an
outbreak and prompted an investigation. Over a
55 month period, increases in clinical isolates
demonstrated 5 epidemic clusters and 1 sporadic
case, lasting for varying periods and separated by
varying time intervals. The outbreak persisted un-
til July 2007 involving 67 newborns and was con-
sidered to be over in August 2007, after the dis-
charge of the last patient infected by S.
marcescens. No other case was recorded in the
NICU until January 2010 when a resumption in
clinical S. marcescens isolates identified the onset
of a new outbreak which lasted 20 months and
involved 58 patients. The outbreak was declared to
be over after the last colonized infant was dis-
charged in August 2011. As of this date to
December 2012, only a few sporadic cases of S.
marcescens colonization were recorded in the
ward. 
Information regarding staffing and crowding of
the NICU was reviewed for the period of the out-
breaks, starting from 2 weeks prior to the first
one, up to 2 weeks after the last S. marcescens
positive culture in each cluster.
Microbiology
During outbreak 1, weekly microbiological cul-
tures from throat and bowel of all NICU patients
were instituted. The bacteriological screenings
were stopped after 2 negative records following
the discharge of the last S. marcescens contami-
nated patient. The carriage testing on all new hos-
pitalized neonates continued even after the last
case in July 2007. At the onset of outbreak 2, mi-
crobiological screenings were taken weekly on
admitted patients. At a later stage, during both
outbreaks, several samples from nurses’ and
physicians’ hands were examined to identify pos-
sible carriers.
Large environmental investigations were per-
formed during clusters III and IV (outbreak 1)
and cluster VI (outbreak 2). Surveillance samples
including air, water, baby incubators, antiseptics,
soap, distilled water, humidifiers, inhalation ther-
apy equipment, sinks, taps, monitors, stetho-
scopes and room surfaces were collected and cul-
turally analyzed to identify possible sources and
reservoir of infection. 
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Clinical specimens included patient blood sam-
ples, cerebrospinal fluid (CSF), tracheal and
bronchial aspirate, urine, surgical wound matter,
gastric juices, stool, conjunctival swabs and
throat swabs. Clinical and surveillance samples
were processed by standard methods (Caroll et
al., 2007). All isolates were studied for phenotyp-
ic identification and antibiotic susceptibility by
means of an automated system (VITEK 2,
BioMérieux, France). The tested antimicrobial
agents included: ampicillin, ampicillin+clavu-
lanate, aztreonam, cefazolin, ceftazidime, cefo-
taxime, ceftriaxone, piperacillin, piperacillin/
tazobactam, gentamicin, amikacin and imipen-
em. ESBL activity and overproduction of
Ampicillinase C (AmpC) were tested by standard
methods (Crivaro et al., 2007). The identified
strains were stored at -70°C for further studies. 
Molecular typing of isolated strains was per-
formed. Only the first patient isolates were in-
cluded in the genetic analysis. The genomic re-
latedness was analyzed by RFLP-PCR, using the
flagellin gene as the target for the PCR amplifi-
cation and RFLP analysis, as described by Parvaz
et al., 2002. Aliquots of amplification products
were digested with AluI endonuclease (Roche
Diagnostic, Penzberg, Germany). Restriction frag-
ment were analyzed by agarose (4%) gel elec-
trophoresis. The analysis of restriction patterns
was elaborated using Diversity Database Software
(Bio-Rad Laboratories, Milan, Italy).
Case-control study
A retrospective case-control study was conducted
among newborns hospitalized in the NICU dur-
ing the outbreak. Cases were defined as neonates
infected or colonized by S. marcescens. Only the
first positive culture was used to define a case. A
positive rectal and/or pharyngeal culture in the
absence of clinical signs and/or symptoms of in-
fection defined the carriage. The presence of clin-
ical signs and/or symptoms compatible with in-
fection and S. marcescens isolated from normal-
ly sterile sites defined the infection. Controls were
defined as neonates admitted to the NICU dur-
ing the outbreak, in whom S. marcescenswas not
isolated in any clinical specimens. Medical
records were reviewed. Data included sex, gesta-
tional age, birth weight, underlying disorders, ad-
ministration of critical care and NICU length of
stay (LOS). The associations were calculated us-
ing contingency table methods and tested for sig-
nificance using Pearson’s chi-square test.
RESULTS
Outbreaks
Seven epidemic clusters followed in the NICU
during the study period, spanning 1-16 months.
Of 127 neonates involved, 84 (66%) were symp-
tom-free colonized while 43 (34%) developed clin-
ical infections. The temporal trend of S.
marcescens clinical cases detected in the ward is
shown in Figure 1. On total cases the median ges-
tational age was 29.5 weeks (27-33.7) with a me-
dian birth weight of 1,192 grams (842.5-2042.5).
Vaginal delivery was recorded in 24% of patients.
Eighty-five percent of newborns were delivered
preterm, and 13% were twins. Babies were born
at the hospital in 85% of cases. The median LOS
in the NICU was 64 days (26-94).
The median LOS in NICU before S. marcescens
acquisition was 15.5 days (7.75-34.25). Central
venous catheterism (CVC) in 39.3% of cases and
mechanical ventilation (MV) in almost 30.7% of
cases were administered. Relative to the infected
patients, their median gestational age was 28
weeks (26.5-34) with a median birth weight of
900 grams (737-1988). Clinical infections had dif-
ferent severity and localization. The most severe
pictures were sepsis (21%) and pneumonia (19%),
related to 3 fatal cases. The overall mortality was
7%. Individual data for 18 patients with systemic
infections are presented in Table 1. Other minor
infections included conjunctivitis (37%), urinary
infections (25%) and lymphadenitis (2%).
Infection control measures
During the first cluster, hospital infection control
strategies and hand-washing protocols were em-
ployed, including the strict observance of the use
of new gloves for each patient, and the adoption
of alcohol-based antiseptic gel in the intensive
care rooms. The NICU was closed to new admis-
sions for 1 month. By cluster III, a strict isolation
policy was instituted; the unit was divided into
infected and non-infected areas and the nurses
were cohorted. In addition to this, intensive staff
educational training regarding hand-washing was
carried out and the operational protocol was
modified, introducing the routine use of alcohol-
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based antiseptic gel. This practice was retained
and is still in use today. During cluster IV, a new
ward reserved for newborns who did not need in-
tensive care was created. The NICU was closed
again to new admissions for two weeks in June
2006, during cluster VI. 
The restriction of hospitalizations was then main-
tained until the termination of the epidemic to
ensure the proper application of the cohorting
and of the other rules of containment which had
been instituted. 
During outbreak 1, the NICU was found to be re-
peatedly overcrowded. The mean NICU occupa-
tion rates were consistently high and frequently
exceeded standard levels, particularly from
January 2003 to December 2005 before the open-
ing of a new ward. During this period the occu-
pation rates reached values of 106%, 113% and
116% respectively in the three first clusters.
Subsequently, the average has not exceeded 93%.
Nursing and professional medical team services
however remained standard during the over-
crowding periods, resulting in a reduced nurse-
to-patient ratio. Overcrowding related to a high
rate of bed occupancy was not found in connec-
tion with the resumption of the outbreak in
January 2010. However, from August 2009 to
May 2010 renovations in the NICU required the
transfer of neonates to a new open space ward.
This temporary arrangement proved inadequate
for the proper management of patients and led to
a situation of high patient density coinciding
with the onset and peak (highest number of cas-
es) of cluster VI.
Microbiology 
A total of 84 symptom-free newborns resulted S.
marcescens colonized, 61% in pharynx, 39% in
bowel, 24% in both sites. The rate of carriers re-
ferring to all patients detected as S. marcescens
positive in the NICU during each cluster epidemic
was 55% in cluster I, 100% in cluster II, 68% in
cluster III, 85% in cluster IV, 0% in cluster V, 57%
in cluster VI, 100% in cluster VII. Cultures of all
samples taken from the hands of healthcare
workers did not show positivity for S. marcescens. 
With regard to the environmental monitoring, the
investigation failed to reveal a point source for
the outbreaks. During outbreak 1, despite the nu-
merous environmental samples examined, only
one strain was obtained from the nozzle of a soap
dispenser. In outbreak 2, two S. marcescens
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FIGURE 1 - Patients infected or colonized by S. marcescens distributed by date of the first positive culture from
January 2003 to December 2012.
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TABLE 1 - Characteristics of 18 neonates infected with S. marcescens in the NICU from 2003 to 2010.
Cluster/case Date m/y RFLP-PCR Birth Gestational Birth Risk factors Type of Isolate - LOS in Total LOS
number (pattern) location age weight or underlying infection body site NICU prior in NICU 
(wks) (gr) disorders to infection (days)
(days)
I/1 03/2003 A Inborn 28 840 CVC, MV Pneumonia Respiratory 16 94
I/2 03/2003 A Outborn 33 980 CVC Sepsis, Blood, 6 66
meningitis, gastrointestinal
brain 
abscess
I/3* 03/2003 A Outborn 27 865 CVC Sepsis Blood, 15 19*
gastrointestinal, 
respiratory
III/4 01/2004 C Inborn 25 900 CVC, VPS Sepsis Blood 54 68
III/5 03/2004 C Inborn 27 800 - Pneumonia Respiratory 61 92
III/6 03/2004 D Outborn 35 1,876 CVC Sepsis Blood, 0 26
pharynx, 
gastrointestinal
III/7 04/2004 D Inborn 24 749 MV Sepsis Blood, 3 109
gastrointestinal
III/8 06/2004 B Inborn 24 632 CVC, MV Pneumonia Pharynx, 9 14*
respiratory
IV/9 10/2005 B Inborn 23 660 Cardiopathy,  Pneumonia Respiratory 12 186
NEC,
retinopathy
IV/10 05/2006 G Inborn 26 680 CVC Clinical Pharynx, 64 82
sepsis gastrointestinal
V/11 01/2007 F Inborn 27 664 CVC, MV Pneumonia Respiratory 39 73
V/12 01/2007 C Inborn 35 2,593 CVC, MV, Sepsis Blood, 12 38
surgery surgical 
wound
V/13 07/2007 A Inborn 38 2,720 CVC, MV, Sepsis Blood 51 67
surgery
VI/14 05/2010 E Inborn 25 735 CVC, MV, Sepsis Blood, 41 97
surgery gastrointestinal
VI/15 05/2010 H Inborn 25 857 CVC, MV, Pneumonia Respiratory 21 140
surgery 
VI/16 06/2010 A Inborn 26 950 CVC, MV Sepsis Blood, 3 10*
gastrointestinal 
VI/17 06/2010 A Inborn 26 690 CVC, MV Pneumonia Respiratory, 85 142
fharynx
VI/18 07/2010 A Inborn 33 1970 Anatomics Pneumonia Respiratory, 12 173
alterations conjunctiva, 
VM, CVC gastrointestinal
RFLP-PCR: Restriction Fragment Length Polymorphism - Polymerase Chain Reaction; LOS: length of stay; CVC: central venous catheterism; MV: mechanical
ventilation; NEC: necrotizing enterocolitis; Clinical sepsis: presence of clinical signs and symptoms of sepsis infection with at least two abnormal laboratory re-
sults when blood culture is negative. *Patient death.
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FIGURE 3 - Tem -
porally trend of four
main epidemic clo -
nes of S. marcescens
during 2 outbreaks in
NICU.
FIGURE 2 -Representative RFLP-PCR banding patterns
of S. marcescens isolates recovered during 2 outbreaks in
NICU. Lane 1: DNA molecular standard; lane 2: pattern
Ax57 strains; lane 3: pattern Bx28 strains; lane 4: pattern
Cx10 strains; lane 5: pattern Dx2 strains; lane 6: pattern
Ex15 strains; lane 7: pattern Fx4 strains; lane 8: pattern
Gx5 strains; lane 9: pattern Hx1 strain; lane 10: pattern
Ix1 strain; lane 11: pattern Lx1 strain; lane12: pattern
Mx1 strain; lane 13: pattern Nx2 strains.
strains were found, one from a surface swab and
one from respiratory equipment, probably con-
taminated by the hands of operators. 
During the study period, a total of 21,011 sam-
ples were analyzed. A total of 467 strains were
identified from: blood (30), tracheal aspirate (34),
urine (36), surgical wound matter (2), gastric
juice (4), conjunctival swabs (34), throat swabs
(216) and stool (121), with the highest value of
positivity found in urine and throat swabs cul-
tures (7% in both) followed by tracheal aspirate
and stool cultures (5% and 6% respectively).
Phylogenetic analysis classified the 127 examined
strains into 12 patterns (A, B, C, D, E, F, G, H, I,
L, M, N) of which four more frequently found:
57xA (45%), 28xB (22%),15xE (12%) and 10xC
(8%) Figure 2. The trend of the different clones
during the observation period is shown in Figure
3. In outbreak 1, genotype A was related to clus-
ters I and IV, and to the last sporadic case.
Genotype B was found in clusters II, III and IV.
Genotype C appeared in clusters III and persist-
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FIGURE 4 - Distribution of unrelated S.
marcescens genotypes in infection and
colonization cases in NICU.
TABLE 2 - Statistical analysis of risk factors associated with S. marcescens infection and colonization
Characteristics S. marcescens case patients n (%) p value
Infections Colonizations Total Total control 
infections/colonizations patients
43 (33.8) 84 (66.1) 127 160
Sex n (%) 0.867
Males 21 (48.8) 49 (58.3) 72 (56.7) 88 (55.0)
Females 22 (51.2) 35 41.7) 55 (43.3) 72 (45.0)
Birth weight 0.001
<1000 22 (51.2) 21 (25.0) 43 (33.8) 18 (11.2)
>1000 <1500 7 (16.2) 25 (29.7) 32 (25.1) 29 (18.1)
>1500 <2500 10 (23.2) 20 (23.8) 30 (23.6) 52 (32.5)
>2500 4 (9.3) 18 (21.4) 22 (17.3) 61 (38.1)
Gestational age 0.001
≤26 weeks 13 (30.2) 11 (13.0) 24 (18.9) 6 (3.7)
27 to 32 weeks 19 (44.1) 42 (50.0) 61 (48.0) 50 (32.2)
33 to 37 weeks 8 (18.6) 15 (17.8) 23 (18.1) 56 (35.1)
>37 weeks 3 (6.9) 16 (19.0) 19 (14.9) 48 (30.0)
Critical care 0.01
CVC 6 (13.9) 9 (10.7) 15 (11.8) 28 (17.5)
MV 2 (4.6) 7 (8.3) 9 (7.0) 24 (15.0)
CVC +  MV 13 (30.2) 7 (8.3) 20 (15.7) 36 (22.5)
CVC +  MV + surgery 6 (13.9) 3 (3.5) 9 (7.0) 11 (6.9)
None 16 (37.2) 58 (69.0) 74 (58.2) 61 (38.1)
Underlying disorders 0.295
Hydrocephalus 0 2 (2.3) 2 (1.5) 4 (2.5)
Intrauterine growth retard 5 (11.6) 3 (3.5) 8 (6.3) 15 (9.3)
Anatomic alterations 4 (9.3) 9 (10.7) 13 (10.2) 7 (4.3)
Respiratory distress 18 (41.8) 14 (16.6) 32 (25.1) 37 (23.1)
None 16 (37.2) 56 (66.6) 72 (56.7) 97 (60.6)
Mean LOS, days, 57.8±42.61 27.6±26.66 
SD, (range) (1-192) (2-120)
CVC: central venous catheterism; MV: mechanical ventilation; LOS: length of stay.
ed in cluster IV and V. Other minor clones (D, E,
F, G) have emerged in clusters III, IV and V. In
outbreak 2, the genetic strain A recurred as dom-
inant clone with strain E and other new minor
strains (H, I, L, M, N). The relation of the differ-
ent genotypes to cases of infection and coloniza-
tion is shown in Figure 4. 
The prevalent clones (A, B, C, E) resulted in both
infection and colonization groups. Sepsis was as-
sociated with 4xA, 2xC, 2xD, 1xE, 1xG, pneumo-
nia with 3xA, 2xB, 1xC, 1xF, 1xH and cases of
mortality with 2xA and 1xB. Genotype A proved
to be the main epidemic.
Regardless of the different genetic pattern, all S.
marcescens isolates except one (type E) in out-
break 1 displayed identical antibiograms. All
strains belonging to patterns A, B, C, D, F and G
were susceptible to ceftriaxone, ceftazidime, ce-
fotaxime, cefepime, imipenem, meropenem,
aztreonam, ciprofloxacin, levofloxacin, gentam-
icin, piperacillin, amikacin and trimethoprim-sul-
phamethoxazole. Pattern E strains were resistant
to gentamicin, piperacillin and amikacin. No re-
duced susceptibility to extended-spectrum
cephalosporins was found in isolated strains (cef-
tazidime and cefotaxime minimum inhibitory
concentration ≤1 µ/mL). 
During outbreak 2, instead, ESBL activity
emerged in strains of type A and was found in 40
of 42 of isolates. The same character of antibiot-
ic resistance was also highlighted in all the iso-
lates of types I and L. All ESBL positive strains
showed a similar pattern with limited sensitivity
to imipenem, meropenem, levofloxacin, piperacil -
lin/tazobactam, trimethoprim/sulfamethoxazole.
The search for beta-lactamase AmpC was con-
stantly negative. The other strains belonging to
pattern E, H, M and N showed no ESBL activity
with a pattern of resistance limited to ampicillin
and cefazolin.
Case-control study 
A total of 287 patients were considered in the
case-control study, including 127 cases and 160
controls. Statistical analysis identified birth
weight, gestational age, required critical care and
LOS as significant risk factors (RFs) associated
with S. marcescens clinical illness or carriage
(Table 2). Sex and underlying disorders were not
statistically significantly associated with S.
marcescens acquisition. 
DISCUSSION 
A program of “alert” organisms surveillance in-
cluding S. marcescens in the mainly high-risk set-
tings was operating in Modena University
Hospital at the onset of the first epidemic cluster.
This program provides preventive strategies such
as: daily monitoring of “alert” pathogens, storage
of isolates, filing and computer analysis of data
by a software package. This allowed us to recog-
nize the epidemic emergency in a timely fashion
and to start appropriate control measures.
The results of these activities implemented in the
NICU seem to have affected the severity and con-
tainment of the epidemics, as found in other stud-
ies (Polilli et al., 2011; Maltezu et al., 2012; Rabier
et al., 2008; Bayramoglu et al., 2011; Jang TN et
al., 2001). In particular, the associated mortality
rate of 7% that we recorded is lower than those
reported in literature, ranging between 10 and
20% (Fleish et al., 2002; Arslan et al., 2010;
Bizzarro et al., 2007).
Periodic cultural screening on all newborns and
the subsequent genotyping of the isolates, allowed
the quick identification of both colonized and
symptomatic patients, and the timely cohorting
and strategic clinical response. Moreover, the
screening facilitated precise tracking of the
spread of the bacterial strains in the NICU. The
diffusion of the molecular typing results among
staff members was deemed to have played an im-
portant educative role regarding the cross-trans-
mission mechanisms of the epidemic strains, as-
sisting in underlining the appropriateness of pro-
posed infection control measures.
High patient density and under-staffing, which
have been identified as important reasons for
breaches in standard hygiene procedures, are sus-
pected to contribute to the outbreaks reported in
this study. 
Overcrowding was addressed during cluster IV
with the opening of a new ward for neonates not
requiring intensive care. Since then, only 3 in-
fection cases were recorded until the conclusion
of the first epidemic and no other clinical cases
occurred during the subsequent 29 months. 
The case control studies identified significant risk
factors including reduced gestational age and
birth weight, intensive care support requirement
and longer NICU stay which have also been high-
lighted in other investigations (Voelz et al., 2010).
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Colonizations or less serious infections were more
often associated with healthier, older newborn
infants. The high percentage of carriers in phar-
ynx and bowel found in the studied patients sup-
ports the suggestion that colonized babies are the
most important reservoir of the microorganism
(Miranda et al., 1996; Voelz et al., 2010; Sarvikivi
et al., 2004).
During the outbreaks, different S. marcescens
genotypes were identified by RFLP-PCR. The
identification of Serratia heterogeneous strains in
long-lasting outbreaks seems mainly due to the
genetic instability of this microorganism as well as
entry of new strains in the ward, in accordance
with other published findings (Parvaz et al., 2002;
Manning et al., 2001; Friedman et al., 2008). A
more virulent strain is usually responsible for clin-
ical cases of infection, while other minor strains
are usually associated with asymptomatic colo-
nization (Maltezu et al., 2012; Rabier et al., 2008;
Bayramoglu et al., 2011; Cimolai et al., 1997). 
A relationship between genetic patterns and in-
trinsic virulence factors cannot be concluded in
this report, as the different clones were related to
both infection and colonization cases. Most of
the clones were involved in more than one clus-
ter and remained for a long time in the ward. Of
special note, strain A involved in the first clinical
cases was related again to the last case of out-
break 1 and to 42 cases of outbreak 2, therefore
it persisted in the NICU for 8 years. In addition,
genotype E, which appeared in May 2004, resur-
faced in April 2010 during the second epidemic.
These observations support the hypothesis that
S. marcescens strains may determine environ-
mental colonization persisting for a long time in
the ward, even though investigations fail to find
any point of source.
The index case of outbreak 1 was identified in an
extremely low-weight preterm baby, born at our
hospital by surgical delivery. 
The newborn infant was immediately placed in
the NICU and colonization occurred 36 days fol-
lowing admission. The source of the first infec-
tion was never identified. The onset of outbreak
2 in January 2010 is related to the admission to
the NICU of a patient from another hospital, who
had sepsis due to an ESBL-producing Klebsiella
pneumoniae strain. A few days after her admis-
sion in the ward the baby was a carrier of ESBL-
producing S. marcescens strain of type A. ESBL
activity in S. marcescensmight be likely acquired
through horizontal gene transfer from the K.
pneumoniae strain. 
This ESBL-producing clone A spread rapidly in
the ward claiming the second epidemic as the
dominant strain. During both epidemics cross-
transmission through staff hand or temporarily
contaminated instruments was suggested by
three isolates: one from the nozzle of a soap dis-
penser, one from a surface swab and one from a
respiratory equipment. ESBL-producing S.
marcescens strains had never been isolated be-
fore in the ward though ESBL-producing Gram-
negative bacteria (mainly K. pneumoniae and
Escherichia coli) have constantly increased in re-
cent years in our NICU. 
In fact, the ESBL isolation rate has risen from
10% in 2008 to 43% in 2010. During the peak of
outbreak 2 in July 2010, 93% of patients had
Gram-negative ESBL-producing strains. In par-
ticular, 23 neonates who gained S. marcescens
had simultaneous colonization by other ESBL-
producing bacteria, resulting in 4 cases of inva-
sive infections. 
Besides conjugal plasmid transfer, empiric an-
timicrobial therapy with ampicillin and gentam-
icin practised in this NICU might have con-
tributed to selection and spread of ESBLs in the
ward. The acquisition of new resistance traits can
alter the microbial ecology of the department ex-
acerbating the difficulty of treatment and control
of micro-organisms involved in the outbreak. In
particular, cause for concern is the emergence
and persistence in the ward of the highly diffusive
genetically mutated strain A.
The authors believe that S. marcescens may be
endemic in this NICU requiring constant adhe-
sion to the protocols introduced to avoid further
epidemic spreads. Molecular typing of isolates
proved to be a very useful tool for identification
and tracing of consecutive epidemic clusters in-
volving genetically unrelated clones. It should be
considered that strain heterogeneity itself does
not exclude an outbreak.
The results of this observation period confirm the
ability of S. marcescens to implant in the wards,
to remain even if not recognized for long periods
and to determine new episodes in critical mo-
ments. Thus, it is essential to remain vigilant
while maintaining strictly control strategies. In
this centre’s NICU the overcrowding limitation,
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the cohorting and the isolation practices along
with intensive staff training, performed to guar-
antee adherence to adopted surveillance proto-
cols, have contributed to the control of
S.marcescens spread in the ward. In addition to
this, the measures applied for S.marcescens lim-
itation seem to have had a positive impact on the
cross-transmission of all multidrug-resistant
Gram-negative bacteria in the NICU. In fact, the
monitoring of the last two years of observation
had shown a downward trend in ESBLs detec-
tion, recording rates of 10% in 2011 and 7% in
2012. Since the selection, the emergence and cir-
culation of new multidrug-resistant strains are
favoured by the same risk factors highlighted for
S. marcescens acquisition, the same strategies can
be validly applied in NICUs for the control of oth-
er horizontally transmitted pathogens.
ACKNOWLEDGEMENTS
The authors would like to thank Johanna Chester
and Francesca Nalin for their critical revision.
COMPETING INTERESTS
There are no financial arrangements or other re-
lationships that could be construed as a conflict
of interest.
FUNDING
Funding from the Parents Association in Support
of Neonatal Department, Policlinico of Modena,
“Pollicino” which is sustained by private dona-
tions and independent initiatives, was used to re-
imburse the critical revision by Johanna Chester,
acknowledged above. There were no other fund-
ing arrangements for this project.
REFERENCES
ARSLAN U., ERAyMAN I., yUKSEKKAyA S., CIMEN O.,
TUNCER I., BOzDOGAN B. (2010). Serratia marcescens
sepsis outbreak in a neonatal intensive care unit.
Pediatr. Int. 52, 208-212.
ASSADIAN O., BERGER A., ASPOCK C., MUSTAFA S.,
KOHLHAUSER C., HIRSCHL A.M. (2002). Nosocomial
outbreak of Serratia marcescens in a neonatal in-
tensive care unit. Infect. Control Hosp. Epidemiol.
23, 457-461.
BAyRAMOGLU G., BURUK K., DINC U., MUTLU M., yLMAz
G., ASLAN y. (2011). Investigation of an outbreak
of Serratia marcescens in a neonatal intensive care
unit. J. Microbiol. Imunol. Infect. 44, 111-115.
BIzzARRO M.J., DEMBRy L.M., BALTIMORE R.S.,
GALLAGHER P.G. (2007). Case-control analysis of en-
demic Serratia marcescens bacteremia in a neona-
tal intensive care unit. Arch. Dis. Child Fetal
Neonatal. 92, 120-126.
BOSI C., DAVIN-REGLI A., CHARREL R., ROCCA B., MONNET
D., BOLLET C. (1996). Serratia marcescens nosoco-
mial outbreak due to contamination of hexetidine
solution. J. Hosp. Infect. 33, 217-224.
BUFFET-BATAILLON S., RABIER V., BéTRéMIEUx P.,
BEUCHéE A., BAUER M., PLADyS P., ET AL. (2009).
Outbreak of Serratia marcescens in a neonatal in-
tensive care unit: contaminated unmedicated liq-
uid soap and risk factors. J. Hosp. Infect.72, 17-
22.
CARROLL K.C., WEINSTEIN M.P. (2007). Manual and au-
tomated system for detection and identification of
microorganisms. In: Murray PR, Baron EJ, Landry
ML, Jorgensen JH, Pfaller MA, editors. Manual of
clinical microbiology. 9th ed. Washington: ASM
Press. 192-217.
CIMOLAI N., TROMBLEy C., WENSLEy D., LE BLANC J.
(1997). Heterogeneous Serratia marcescens geno-
types from a nosocomial pediatric outbreak. Chest.
111, 194-197.
CIVEN R., VUGIA D.J., ALExANDER R., BRUNNER W.,
TAyLOR S., PARRIS N., ET AL. (2006). Outbreak of
Serratia marcescens infections following injection
of betamethasone compounded at a community
pharmacy. Clin. Infect. Dis. 43, 831-837.
CRIVARO V., BAGATTINI M., SALzA M.F., RAIMONDI F.,
ROSSANO F., TRIASSI M., ET AL. (2007). Risk factors
for extendet-spectrum β-lactamase-producing
Serratia marcescens and Klebsiella pneumoniae ac-
quisition in a neonatal intensive care unit. J. Hosp.
Infect. 67, 135-141.
CULLEN M.M., TRAIL A., ROBINSON M., KEANEy M.,
CHADWICK P.R. (2005). Serratia marcescens outbreak
in a neonatal intensive care unit prompting review
of decontamination of laryngoscopes. J. Hosp.
Infect. 59, 68-70.
DAVID M.D., WELLER T.M.A., LAMBERT P., FRAISE A.P.
(2006). An outbreak of Serratia marcescens on the
neonatal unit: a tale of two clones. J. Hosp. Infect.
63, 27-33.
ENCISO-MORENO J.A., PERNAS-BUITRON N., ORTIz-
HERRERA M., CORIA-JIMENEz R. (2004).
Identification of Serratia marcescens populations
of nosocomial origin by RAPD-PCR. Arch. Med. Res.
35, 12-17. 
FLEISCH F., zIMMERMANN-BAER U., zBINDEN R., BISHOFF
G., ARLETTAz R.,VALDVOGEL K., ET AL. (2002). Three
consecutive outbreaks of Serratia marcescens in a
neonatal intensive care unit. Clin. Infect. Dis. 34,
767-773.
FRIEDMAN N.D., KOTSANAS D., BRETT G., BILLAH B.,
KORMAN T.M. (2008). Investigation of an outbreak
of Serratia marcescens in a neonatal unit via a case-
382 C. Casolari et al.
control study and molecular typing. Am. J.Infect.
Control. 36, 22-28.
GILES M., HARWOOD H.M., GOSLING D.A., HENNESSy D.,
PEARCE C.T., DALEy A.J. (2006). What is the best
screening method to detect Serratia marcescens col-
onization during an outbreak in a neonatal inten-
sive care nursery? J. Hosp. Infect. 62, 349-352.
GILLESPIE E.E., BRADFORD J., BRETT J., KOTSANAS D.
(2007). Serratia marcescens bacteremia–an indica-
tor for outbreak management and heightened sur-
veillance. J. Perinat. Med. 35, 227-231.
HEJAzI A., FALKINER F.R. (1997). Serratia marcescens.
J. Med. Microbiol. 46, 903-912.
HEJAzI A., KEANE C.T., FALKINER F.R. (1997). The use of
RAPD-PCR as a typing method for Serratia
marcescens. J. Med. Microbiol. 46, 913-919.
JANG T.N., FUNG C.P., yANG T.L., SHEN S.H., HUANG
C.S., LEE S.H. (2001). Use of pulsed-field gel elec-
trophoresis to investigate an outbreak of Serratia
marcescens infection in a neonatal intensive care
unit. J. Hosp. Infect. 48, 13-19.
LIGOzzI M., FONTANA R., ALDEGHERI M., SCALET G., LO
CASCIO G. (2010). Comparative evaluation of an au-
tomated repetitive-sequence-based PCR instrument
versus pulsed-field gel electrophoresis in the set-
ting of a Serratia marcescens nosocomial infection
outbreak. J. Clin. Microbiol. 48, 1690-1695.
MADANI T.A., ALSAEDI S., JAMES L., ELDEEK B.S., JIMAN-
FATANI A.A., ALAWI M.M., ET AL. (2011). Serratia
marcescens-contaminated baby shampoo causing
an outbreak among newborns at King Abdulaziz
University Hospita, Jeddah, Saudi Arabia. J. Hosp.
Infect. 78,16-19.
MALTEzU H.C., TRyFINOPOULOU K., KATERELOS P., FTIKA
L., PAPPA O., TSERONI M., ET AL. (2012). Consecutive
Serratia marcescensmulticlone outbreaks in neona-
tal intensive care unit. Am. J. Infect. Control. 40,
637-642.
MANNING M.L., ARCHIBALD L.K., BELL L.M., BANERIJEE
S.N., JARVIS W.R. (2001). Serratia marcescens trans-
mission in a pediatric intensive care unit: a multi-
factorial occurrence. Am. J. Infect. Control. 29, 115-
119.
MARAGAKIS L.L., WINKLER A., TUCKER M.G., COSGROVE
S.E., ROSS T., LAWSON E. ET AL. (2008). Outbreak of
multidrug-resistant Serratia marcescens infection
in a neonatal intensive care unit. Infect. Control
Hosp. Epidemiol. 29, 418-423.
MILISAVLJEVIC V., WU F., LARSON E., RUBENSTEIN D.,
ROSS B., DRUSIN L.M., ET AL. (2004). Molecular epi-
demiology of Serratia marcescens outbreaks in two
neonatal intensive care units. Infect Control Hosp.
Epidemiol. 25, 719-721.
MIRANDA G., KELLy C., SOLORzANO F., LEANOS B., CORIA
R., PATTERSON J.E. (1996). Use of pulsed-field gel
electrophoresis typing to study an outbreak of in-
fection due to Serratia marcescens in a neonatal in-
tensive care unit. J. Clin. Microbiol. 34, 3138-3141.
MIRANDA-NOVALES G., LEANOS B., DIAz-RAMOS R.,
GONzALES-TEJEDA L., PEREGRINO-BEJARANO L.,
VILLEGAS-SILVA R., ET AL. (2003). An outbreak due to
Serratia marcescens in a neonatal intensive care unit
typed by 2-day pulsed field gel electrophoresis pro-
tocol. Arch. Med. Res. 34, 237-241.
PARVAz P., TILLE D., MEUGNIER H., PERRAUD M.,
CHEVALLIER P., RITTER J., ET AL. (2002). A rapid and
easy PCR-RFLP method for genotyping Serratia
marcescens strains isolated in different hospital out-
breaks and patient environments in the Lyon area,
France. J. Hosp. Infect. 51, 96-105.
PEROTTI G., BERNARDO M.E., SPALLA M., MATTI A.,
STRONATI M., PAGANI L. (2007). Rapid control of two
outbreaks of Serratia marcescens in a Northern
Italian neonatal intensive care unit. J. Chemoter.
19, 56-60.
POLILLI E., PARRUTI G., FAzII P., D’ANTONIO D., PALMIERI
D., D’INCECCO C., ET AL. (2011). Rapidly controller
out break of Serratia marcescens infection/coloni-
sations in a neonatal intensive care unit, Pescara
General Hospital, Pescara, Italy. Euro Surveill. 16,
pii 19892.
PRASAD G.A., JONES P.G., MICHAELS J., GARLAND J.S.,
SHIVPURI C.R. (2001). Outbreak of Serratia
marcescens infection in a neonatal intensive care
unit. Infect. Control Hosp. Epidemiol. 22, 303-305. 
RABIER V., BATAILLON S., JOLIVET-GOUGEON A., CHAPPLAIN
J.M., BEUCHéE A., BéTRéMIEUx P. (2008). Hand
washing soap as a source of neonatal Serratia
marcescens outbreak. Acta Pediatr. 97, 1381-1385.
SARTOR C., JACOMO V., DUVIVIER C., TISSOT-DUPONT H.,
SAMBUS R., DRANC M. (2000). Nosocomial Serratia
marcescens infections associated with extrinsic con-
tamination of a liquid nonmedicated soap. Infect.
Control Hosp. Epidemiol. 21, 196-199.
SARVIKIVI E., LyyTIKAINEN O., SALMENLINNA S., VUOPIO-
VARKILA J., LUUKKAINEN P., TARKKA E. ET AL. (2004).
Clustering of Serratia marcescens infections in a
neonatal intensive care unit. Infect. Control Hosp.
Epidemiol. 25, 723-729.
STEPPBERGER K., WALTER S., CLAROS M.C., SPENCKER
F.B., KIESS W., RODLOF A.C., ET AL. (2002).
Nosocomial neonatal outbreak of Serratia
marcescens: analysis of pathogens by pulsed field
gel electrophoresis and polymerase chain reaction.
Infection. 30, 277-281.
VILLARI P., CRISPINO M., SALVADORI A., SCARCELLA A.
(2001). Molecular epidemiology of an outbreak of
Serratia marcescens in a neonatal intensive care
unit. Infect. Control Hosp. Epidemiol. 22, 630-634.
VOELz A., MULLER A., GILLEN J., DRESBACH T., ENGHELHART
S., BATES C.J., ET AL. (2010). Outbreaks of Serratia
marcescens in neonatal and pediatric intensive care
units: clinical aspects, risk factors and management.
Int. J. Hyg. Environ. Health. 213, 79-87.
Two consecutive outbreaks of Serratia marcescens occurred in a neonatal intensive care unit 383

